Beyond Skin Deep: Unravelling the challenges of managing eczema
Join Dr Artiene Tatian, dermatologist and Ms Melanie Funk to discuss the impact and burden of eczema on individuals and practical tips for managing patients with eczema. Hosted by Medcast medical adviser, Dr Kate Annear.
About the Podcast
Eczema is an increasingly common condition that is often managed in the primary care setting. It usually presents early in life and is often viewed as a minor condition. However, this belies the reality that for many sufferers, eczema can be a debilitating chronic condition. Ongoing management can be complex, time-consuming, and expensive, with patients and their families experiencing physical, mental, emotional, and financial burdens.
This podcast covers:
-
The impact and burden of eczema on individuals and families in Australia.
-
Some of the challenges that health professionals are facing in treating patients with eczema.
-
Some practical advice that health professionals can take home including clinical tips and suggested resources to use with patients.
-
We will also be introducing the QUM Alliance eczema program and the educational activities that will follow in the coming months.
This podcast is brought to you by Medcast and the Quality Use of Medicines Alliance.
For more free Quality Use of Medicines education, check out QHUB on Medcast
While the “gold standard” is clear, real-world pressures can put surgical safety to the test. A packed surgical list, a late patient arrival, and a surgeon asking to “hurry up” can all create the temptation to cut corners. Time pressure is one of the biggest threats to safety culture.
The Huddle is your space to pause, reflect and grow as a nurse. Whether you’re on your commute, in the tea room, or walking the dog, each episode is designed to bring you practical insights, clinical reasoning tips, and stories from the frontline of nursing.
Quality Use of Medicines Alliance
Wearables with PPG or ECG capabilities can identify episodes of irregular heart rhythms suggestive of AF, but should not replace traditional methods of diagnosis, such as a 12-lead ECG. Evidence of accuracy and positive predictive values from prospective, comparative trials involving older populations are limited, and the potential for inconclusive results remains a concern based on current trial findings. Their utility may be highest for symptomatic individuals or those at risk of developing AF.